Insurance company versus big pharma - whose money is it anyway?
Humana Inc. (HUM), a $39 billion health insurance company, accuses Teva Pharmaceutical Industries (TEVA), an $8 billion company, and a few other generic drug makers, of playing ugly in the generic drugs market. In a 610-page complaint filed with a Philadelphia federal court, Humana has accused these companies of conspiring to keep the prices of over 10 dozen generics at high levels. The price collusion scheme, allegedly "spearheaded" by Teva, peaked during 3Q-2013 to 1Q-2015. This new case is a follow-up by Humana of